Koers Clariant AG Other OTC
Aandelen
CLZNY
US18047P1012
Chemische specialiteiten
Omzet 2024 * | 4,29 mld. 4,72 mld. 4,37 mld. | Omzet 2025 * | 4,52 mld. 4,98 mld. 4,61 mld. | Marktkapitalisatie | 4,67 mld. 5,14 mld. 4,76 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 252 mln. 277 mln. 257 mln. | Nettowinst (verlies) 2025 * | 324 mln. 357 mln. 331 mln. | EV/omzet 2024 * | 1,47 x |
Nettoschuld 2024 * | 1,63 mld. 1,79 mld. 1,66 mld. | Nettoschuld 2025 * | 1,51 mld. 1,66 mld. 1,54 mld. | EV/omzet 2025 * | 1,37 x |
K/w-verhouding 2024 * |
18,2
x | K/w-verhouding 2025 * |
14,4
x | Werknemers | - |
Dividendrendement 2024 * |
3,19% | Dividendrendement 2025 * |
3,5% | Vrij verhandelbaar | 62,16% |
Recentste transcriptie over Clariant AG
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Conrad Keijzer
CEO | Chief Executive Officer | 55 | 09-12-20 |
Bill Collins
DFI | Director of Finance/CFO | - | 01-07-22 |
Chief Tech/Sci/R&D Officer | - | 01-02-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Geoffery Merszei
BRD | Director/Board Member | 73 | 16-10-18 |
Director/Board Member | 69 | 29-06-20 | |
Peter Steiner
BRD | Director/Board Member | 64 | 21-04-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,16% | 66,69 mld. | |
+1,79% | 49,2 mld. | |
+17,80% | 41,24 mld. | |
+20,17% | 25,89 mld. | |
+12,56% | 19,81 mld. | |
+2,48% | 17,11 mld. | |
-23,12% | 15,86 mld. | |
+2,62% | 15,35 mld. | |
-8,88% | 15,23 mld. |